Does BEMPEGALDESLEUKIN Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with BEMPEGALDESLEUKIN. This represents 3.5% of all adverse event reports for BEMPEGALDESLEUKIN.
6
Reports of Malignant neoplasm progression with BEMPEGALDESLEUKIN
3.5%
of all BEMPEGALDESLEUKIN reports
4
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BEMPEGALDESLEUKIN?
Of the 6 reports, 4 (66.7%) resulted in death, 5 (83.3%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEMPEGALDESLEUKIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BEMPEGALDESLEUKIN Cause?
Acute kidney injury (9)
Cerebrovascular accident (9)
Hypotension (9)
Atrial fibrillation (7)
Pyrexia (7)
Eosinophilia (5)
Pulmonary embolism (5)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BEMPEGALDESLEUKIN Alternatives Have Lower Malignant neoplasm progression Risk?
BEMPEGALDESLEUKIN vs BENADRYL
BEMPEGALDESLEUKIN vs BENAZEPRIL
BEMPEGALDESLEUKIN vs BENDAMUSTINE
BEMPEGALDESLEUKIN vs BENDROFLUMETHIAZIDE
BEMPEGALDESLEUKIN vs BENIDIPINE